jRCTs032240736RecruitingNot Applicable
A Randomized, Open Label, Parallel Group Comparative Study of the Efficacy and Safety of the Cataract surgery with Hydrus and the Cataract surgery with Tanito Microhook in Patients with Glaucoma and Cataracts.
Not provided0 sites106 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Enrollment
- 106
- Primary Endpoint
- -
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized Controlled Trial
- Intervention Model
- Parallel Assignment
- Primary Purpose
- Treatment Purpose
- Masking
- Open(masking Not Used)
Eligibility Criteria
- Ages
- 40age old over to 90age old not (—)
- Sex
- All
Inclusion Criteria
- •(1) Individuals diagnosed with cataracts
- •(2) Individuals undergoing phacoemulsification and intraocular lens (IOL) implantation
- •(3) Individuals scheduled for the insertion of a monofocal IOL into the lens capsule
- •(4) Individuals with early to moderate primary open-angle glaucoma (with a mean deviation (MD) value of -12dB or higher)
- •(5) Individuals with intraocular pressure between 10mmHg and less than 25mmHg, while using at least one type of glaucoma eye drop
- •(6) Individuals with a clear cornea
- •(7) Age: Individuals between 40 and 89 years old at the time of consent
- •(8) Gender: Not specified
- •(9) Individuals who, after receiving a sufficient explanation about participating in this study and fully understanding it, provide written informed consent of their own free will
- •(10) Individuals able to attend follow-up outpatient visits according to the study schedule
Exclusion Criteria
- •(1) Individuals with exfoliation glaucoma, angle-closure glaucoma, or secondary glaucoma in the subjected eye.
- •(2) Individuals with narrow angles classified as Shaffer grade I or II in the subjected eye.
- •(3) Individuals with a corneal endothelial cell density of less than 1500 cells/mm2 in the subjected eye.
- •(4) Individuals with congenital angle abnormalities, peripheral anterior synechiae (PAS), neovascularization, or other angle abnormalities that pose a risk of improper microstent insertion in the subjected eye.
- •(5) Individuals with a history of allergy to nitinol (Nickel titanium)
- •(6) Individuals with a history of corneal surgery that could affect intraocular pressure measurements in the subjected eye.
- •(7) Patients with a history of glaucoma surgery or laser treatment (such as SLT or TSCPC) in the subjected eye
- •(8) Individuals with other active eye diseases besides glaucoma in the subjected eye.
- •(9) Individuals with an axial length of 30mm or more in the subjected eye.
- •(10) Individuals using only dorzolamide hydrochloride/timolol maleate combination eye drops in the subjected eye.
- •(11) Individuals with a history of allergy to dorzolamide hydrochloride/timolol maleate combination eye drops
- •(12) Any other individual deemed inappropriate for participation in this study by the principal or co-investigators
Outcomes
Primary Outcomes
-
Success rate of intraocular pressure (IOP) control at 6 months postoperatively.
Secondary Outcomes
No secondary outcomes reported
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Efficacy and safety of trabeculectomy ab interno with Kahook DualBladeprimary open angle glaucomaDRKS00025194niversitätsklinikum Ulm; Augenheilkunde30
Completed
Not Applicable
The study for surgical outcome of trabeculectomy for neovascular glaucomatous patients who received an additional bevacizumab treatment after the surgery.Patients with neovascular glaucomaJPRN-UMIN000000895Kumamoto University40
Completed
Not Applicable
The study for surgical outcome of trabeculectomy for neovascular glaucomatous patients who received bevacizumab treatment before the surgery.Patients with neovascular glaucomaJPRN-UMIN000001136Kumamoto University40
Completed
Phase 3
Trabeculectomy with versus without intravitreal bevacizumab in diabetic patientsGlaucoma.GlaucomaIRCT2014102219206N3vice chancellor of research,Iran University of Medical Sciences52
Active, not recruiting
Not Applicable
Clinical trial to study the effect of using a filtration surgery to reduce eye pressure called Trabeculectomy (creating new opening at angle) alone compared to a combination of Trabeculectomy and a deep sclerectomy (removing extra white tissue of eye) surgery for glaucomaCTRI/2018/04/013005All India Institute Of Medical Sciences